Skip to search boxSkip to navigationSkip to main content

Diagnosis and classification of optic neuritis

  • Axel Petzold(corresponding author)
    ,
  • Clare L. Fraser
    ,
  • Mathias Abegg
    ,
  • Raed Alroughani
    ,
  • Daniah Alshowaeir
    ,
  • Regina Alvarenga
*Corresponding author for this work
  • University College London
    ,
  • Academic Medical Center
    ,
  • Moorfields Eye Hospital NHS Foundation Trust
    ,
  • University of Sydney
    ,
  • University of Bern
    ,
  • Al-Amiri Hospital
Research Output:
Contribution to journal
Review article
Peer-review

Open access

Publication Information

Output type

Research Output:
Contribution to journal
Review article
Peer-review

Original language

English

Pages from-to (Number of pages)

Pages 1120-1134 (15 pages)

Journal (Volume, Issue Number)

The Lancet Neurology (Volume 21, Issue 12)

Publication milestones

  • Published - 12/2022

Publication status

Published - 12/2022

ISSN

1474-4422

Publication IDs

  • Scopus: 85141992725
  • PubMed: 36179757

Abstract

There is no consensus regarding the classification of optic neuritis, and precise diagnostic criteria are not available. This reality means that the diagnosis of disorders that have optic neuritis as the first manifestation can be challenging. Accurate diagnosis of optic neuritis at presentation can facilitate the timely treatment of individuals with multiple sclerosis, neuromyelitis optica spectrum disorder, or myelin oligodendrocyte glycoprotein antibody-associated disease. Epidemiological data show that, cumulatively, optic neuritis is most frequently caused by many conditions other than multiple sclerosis. Worldwide, the cause and management of optic neuritis varies with geographical location, treatment availability, and ethnic background. We have developed diagnostic criteria for optic neuritis and a classification of optic neuritis subgroups. Our diagnostic criteria are based on clinical features that permit a diagnosis of possible optic neuritis; further paraclinical tests, utilising brain, orbital, and retinal imaging, together with antibody and other protein biomarker data, can lead to a diagnosis of definite optic neuritis. Paraclinical tests can also be applied retrospectively on stored samples and historical brain or retinal scans, which will be useful for future validation studies. Our criteria have the potential to reduce the risk of misdiagnosis, provide information on optic neuritis disease course that can guide future treatment trial design, and enable physicians to judge the likelihood of a need for long-term pharmacological management, which might differ according to optic neuritis subgroups.

Publication metrics

Metrics

Scopus
Citations

PlumX, opens in new tab

Captures
339
Social media
608
Mentions
38
Citations
213